Skip to content

Christopher Timmermann

Imperial College London, Multidisciplinary Association for Psychedelic Studies

92 papers in the library · 4,613 citations · publishing 2017-2026

Papers

Sort Most recent Most cited

Perspectives on Meditation-based Preparation for Psychedelic Experiences: Insights from Practitioners with Combined Meditation and Psychedelic Experience

Mindfulness August 15, 2026 Rosalind McAlpine, Merve Utanğaç, Joanna Kuć et al.

Abstract Objectives Emerging research suggests that meditation may support more beneficial psychedelic experiences while reducing the likelihood of lasting negative effects, yet its specific preparatory benefits remain underexplored. This study aimed to investigate the perceived utility of meditation as a preparatory tool for enhancing positive outcomes and reducing negative effects during...

How to set up a psychedelic study: Unique considerations for research involving human participants.

Neuroscience and Biobehavioral Reviews July 1, 2026 Marcus J. Glennon, Catherine Bird, Prateek Yadav et al. 2 citations

Setting up a psychedelic study can be a long, arduous, and Kafkaesque process. Researchers are faced with a host of challenges in this rapidly evolving field, necessitating a range of considerations that remain largely unstandardised. Many of the complexities inherent to psychedelic research also challenge existing assumptions around, for example, approaches to psychiatric prescribing, the...

A Shared Entropic Axis Spans States of Consciousness Across Pharmacological and Clinical Conditions

bioRxiv Preprint Server June 12, 2026 Dante Sebastián Galván Rial, Gabriel A. Della Bella, Lorina Naci et al. preprint

A general account of how diverse states of consciousness arise from brain activity requires a quantitative framework that generalises across them. The Entropic Brain Theory proposes that states of consciousness can be ordered along a single dimension defined by the entropy of spontaneous neural activity, but this prediction has not been tested across pharmacological and clinical perturbations...

Reorganization of Human Brain Waves Across Diverse States of Consciousness.

bioRxiv : the preprint server for biology June 1, 2026 Panagiotis Fotiadis, Hyunwoo Jang, Rui Dai et al.

Brain waves are ubiquitous phenomena of human brain activity. As they propagate, they coordinate neural communication, shaping conscious perception. Understanding how brain waves unfold across space and time is thus critical for uncovering the neural mechanisms that support and suppress consciousness. Here, we analyzed data from the Human Connectome Project alongside multiple independent human...

On the meaning of ‘plasticity’ in neuroscience and mental health research and its relation to the action of psychedelic therapy

May 13, 2026 Robin Carhart-Harris, Richard J. Zeifman, Lorenzo Pasquini et al. preprint

First-line dictionary definitions of ‘plasticity’ describe it as the ability (of a thing) to be shaped or molded; we call this ‘plasticity proper’. In neuroscience, however, ‘neural plasticity’ or ‘neuroplasticity’ is defined as an induced change in brain function or structure. These two plasticities are not the same. Several (but not all) popular biomarkers of neuroplasticity index part of an...

An international mega-analysis of psychedelic drug effects on brain circuit function

Nature Medicine April 1, 2026 Manesh Girn, Manoj K. Doss, Leor Roseman et al. 8 citations

Psychedelic drugs are re-emerging as promising scientific and clinical tools. However, despite a rapidly expanding literature on their therapeutic value, the neural mechanisms underlying psychedelic effects remain unclear. Resting-state functional magnetic resonance imaging studies of acute psychedelic effects, conducted independently by several research groups, have so far yielded fragmented...

Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.

BMJ Open March 12, 2026 Rosalind McAlpine, Magdalena Jaglinska, Krisztina Jedlovszky et al.

Psychedelic-assisted therapy shows promise for treating various mental health conditions; however, its reliance on intensive psychological preparation limits its broader application. Digital health interventions have the potential to address this limitation by providing structured, accessible and scalable preparation solutions. This randomised controlled feasibility trial aims to evaluate the...

A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.

Nat Med February 16, 2026 David Erritzøe, Tommaso Barba, Tiffanie Benway et al. 4 citations

Major depressive disorder (MDD) is a leading cause of disability worldwide, yet many patients have inadequate responses to current treatments. Dimethyltryptamine (DMT), a serotonergic psychedelic with rapid onset and short duration, shows promise as a potential antidepressant (AD), although clinical evidence in MDD remains limited. We conducted a phase IIa, double-blind, placebo-controlled,...

Brain Dynamics of Classical Psychedelics Show Paradoxical Hierarchical Flattening With Increased Complexity

SSRN Electronic Journal 2026 Jakub Vohryzek, Elvira Garcia Guzman, Morten L. Kringelbach et al. 1 citation

Despite divergent behavioral and phenomenological profiles, both psychedelic states and reduced states of consciousness have been associated with a flattening of the brain's functional hierarchy. To address this apparent paradox, we developed a more specific definition of hierarchy based on the proximity of the brain to thermodynamic equilibrium and then applied it to investigate the changes to...

Computational spirits: a neuroscientific account of psychedelic entity encounters.

Neuroscience of Consciousness 2026 Jonas Mago, George Deane, Lars Sandved-Smith et al.

Under the influence of psychedelics, people often report encountering "entities" who seem to have their own autonomous agency. Depending on the cultural milieu, these entities are reported to take a variety of forms, including spirits, elves, ancestors, or fragments of the self. Encounters with such beings hold a central place in many traditions of psychedelic practice around the world. And...

Micro-phenomenology of immersion and perceived presences under DMT.

Neuroscience of Consciousness 2026 James W. Sanders, Raphaël Millière, Ema Demšar et al.

Psychedelic compound N,N-Dimethyltryptamine (DMT) is renowned for inducing highly immersive experiences, often including encounters with seemingly sentient presences. While such phenomena are well documented, immersion under psychedelics remains conceptually underdefined and phenomenologically underexplored. Here we apply micro-phenomenology to characterize immersion under DMT as a structured...

Open-Ended Inquiry of Psychedelic Experiences via First-Person Methodologies and Neurophenomenology

The MIT Press eBooks December 16, 2025 Christopher Timmermann

Psychedelic compounds act on specific brain pro cesses, which can lead to rich experiences of wide phenomenological breadth.Because of this, psychedelic phenomena pre sent a unique opportunity to explore the tension between the objective and the subjective.However, in-depth first-person approaches fostering inquiry into the psychedelic experience are still underdeveloped in psychedelic science...

Defining ‘psychedelic’

December 4, 2025 Avery Ostrand, Matthew M. Nour, Christopher Timmermann et al. 2 citations preprint

Humphry Osmond coined the term ‘psychedelic’ in 1956, conjoining ‘psyche’ for ‘soul’ and ‘delic’ from ‘dêlos’ for ‘to manifest’ or ‘illuminate.’ Soul-illumination is an adjective that describes a psychological state or process. However, Osmond’s intention was to use the adjective to name— not just a state— but a category of drug that can induce the subjective effect as its principal action;...

A Mesoscale Framework for Psychedelic Drug Action in the Human Brain

bioRxiv November 26, 2025 Rui Dai, Rodrigo Cofré, Christopher Timmermann et al. preprint

The mechanism of psychedelic drug action is a dynamic area of neuroscience, with two major lines of investigation: (1) laboratory studies at the molecular and cellular level, and (2) human neuroimaging studies of functional brain networks. Despite considerable progress, there remains insufficient understanding of the link between molecular/cellular substrates of psychedelics and the whole-brain...

Exploring practitioners' perceptions of health behavior changes associated with psychedelic experiences.

Sci Rep November 25, 2025 Laura C. Carvalho, Jorge Encantado, Michiel van Elk et al.

In addition to evidence supporting the use of psychedelics in treating alcohol and tobacco misuse, emerging research suggests that psychedelic experiences may also facilitate beneficial changes in other health behaviors, such as diet, exercise, and meditation. This retrospective, survey-based study explored perceived health behavior changes following psychedelic experiences, from the...

DMT-induced shifts in criticality correlate with self-dissolution.

The Journal of neuroscience : the official journal of the Society for Neuroscience November 24, 2025 Mona Irrmischer, Marco Aqil, Lisa Luan et al.

Psychedelics profoundly alter subjective experience and brain dynamics. Brain oscillations express signatures of near-critical dynamics, relevant for healthy function. Alterations in the proximity to criticality have been suggested to underlie the experiential and neurological effects of psychedelics. Here, we investigate the effects of a psychedelic substance (DMT) on the criticality of brain...

Complexity as a Potential Neurophysiological Correlate of Awe

bioRxiv (Cold Spring Harbor Laboratory) November 21, 2025 Joseph C. C. Chen, Gabriella Mace, Avery Ostrand et al. preprint

Abstract Awe is a positive emotion often accompanied by sensations of vastness and unity, with known benefits for well-being and social behavior. However, its neural underpinnings remain poorly understood. We recorded electroencephalography (EEG) and autonomic physiology in 23 healthy older participants while they watched a nature-based audiovisual film and subjectively rated awe events. Awe...

Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents

Psychedelics November 15, 2025 Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta et al.

Serotonergic psychedelics like psilocybin and LSD have shown potential therapeutic benefits for mental health conditions, including depression, PTSD, and addiction. However, research remains limited due to regulatory barriers and a lack of diversity in study populations. Spanish-speaking individuals, despite their significant global and U.S. presence, are underrepresented in psychedelic...

Neural effects and phenomenology of nondual meditation and 5-MeO-DMT in an expert meditation practitioner

PsyArXiv September 30, 2025 Christopher Timmermann, Tommaso Barba, James W. Sanders et al. preprint

Meditation and psychedelics have separately been studied as powerful tools for probing consciousness through their capacity to deconstruct the sense of self. Yet, direct empirical comparisons remain scarce, particularly in expert meditators. Here, we report for the first time a case study in which an advanced meditator and Lama from the Mahāmudrā meditation tradition engaged in a traditional...

N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences.

Neuropsychopharmacology September 12, 2025 Jakub Vohryzek, Andrea I. Luppi, Selen Atasoy et al. 2 citations

Exploring the intricate relationship between brain's structure and function, and how this affects subjective experience is a fundamental pursuit in neuroscience. Psychedelic substances offer a unique insight into the influences of specific neurotransmitter systems on perception, cognition and consciousness. Specifically, their impact on brain function propagates across the structural connectome...

An international Delphi consensus for reporting of setting in psychedelic clinical trials.

Nature Medicine June 3, 2025 Chloé Pronovost-Morgan, Kyle T. Greenway, Leor Roseman et al. 26 citations

Psychedelic substances exhibit complex interactions with the 'set and setting' of use, that is, the mental state of the user and the environment in which a psychedelic experience takes place. Despite these contextual variables' known importance, psychedelic research has lacked methodological rigor in reporting extra-pharmacological factors. This study aimed to generate consensus-based...

Psychedelics, attachment, and enculturation dynamics: Prospects and challenges

Journal of Psychedelic Studies May 30, 2025 Esenia K. Cassidy, David Dupuis, Christopher Timmermann et al. 4 citations

Abstract Background & aims This conceptual paper explores the intersection of attachment theory, psychedelic research, and enculturation dynamics. We aim to understand how both attachment patterns and psychedelic use may jointly influence worldview transformations and enculturation processes. Methods We synthesize theoretical perspectives and empirical findings from multiple fields, including...

Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience.

Communications Biology April 18, 2025 S Parker Singleton, Christopher Timmermann, Andrea I. Luppi et al. 17 citations

Psychedelics offer a profound window into the human brain through their robust effects on perception, subjective experience, and brain activity patterns. The serotonergic psychedelic N,N-dimethyltryptamine (DMT) induces a profoundly immersive altered state of consciousness lasting under 20 min, allowing the entire experience to be captured during a single functional magnetic resonance imaging...

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self

Imaging Neuroscience April 16, 2025 Lorenzo Pasquini, Alexander J. Simon, Courtney L. Gallen et al. 4 citations

Abstract N,N-Dimethyltryptamine (DMT) is a serotonergic psychedelic, known to rapidly induce short-lasting alterations in conscious experience, characterized by a profound and immersive sense of physical transcendence alongside rich and vivid auditory distortions and visual imagery. Multimodal neuroimaging data paired with dynamic analysis techniques offer a valuable approach for identifying...

How to set up a psychedelic study: Unique considerations for research involving human participants

arXiv Preprint Archive March 28, 2025 Marcus J. Glennon, Catherine Bird, Prateek Yadav et al.

Setting up a psychedelic study can be a long, arduous, and kafkaesque process. This rapidly-developing field poses several unique challenges for researchers, necessitating a range of considerations that have not yet been standardised. Many of the complexities inherent to psychedelic research also challenge existing assumptions around, for example, approaches to psychiatric prescribing, the...